Cargando…

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease

Chronic kidney disease (CKD) is a major cause of death worldwide and is associated with a high risk for cardiovascular and all-cause mortality. In CKD, endothelial dysfunction occurs and uremic toxins accumulate in the blood. miR-126 is a regulator of endothelial dysfunction and its blood level is d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fourdinier, Ophélie, Glorieux, Griet, Brigant, Benjamin, Diouf, Momar, Pletinck, Anneleen, Vanholder, Raymond, Choukroun, Gabriel, Verbeke, Francis, Massy, Ziad A., Metzinger-Le Meuth, Valérie, Metzinger, Laurent, Group-EUTox, on behalf of the European Uremic Toxin Work
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508835/ https://www.ncbi.nlm.nih.gov/pubmed/34638892 http://dx.doi.org/10.3390/ijms221910549

Ejemplares similares

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
por: Brigant, Benjamin, et al.
Publicado: (2018)

miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress
por: Mondadori dos Santos, Ana, et al.
Publicado: (2015)

miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools
por: Metzinger-Le Meuth, Valérie, et al.
Publicado: (2019)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
por: Hamza, Eya, et al.
Publicado: (2020)

miR‐126‐3p is essential for CXCL12‐induced angiogenesis
por: Bassand, Kévin, et al.
Publicado: (2021)

The Role of Non-Coding RNAs in Kidney Diseases
por: Metzinger, Laurent, et al.
Publicado: (2022)

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
por: Borges Bonan, Natalia, et al.
Publicado: (2019)

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2020)

Aortic valve calcification in the era of non-coding RNAs: The revolution to come in aortic stenosis management?
por: Nader, Joseph, et al.
Publicado: (2020)

Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223
por: Rangrez, Ashraf Yusuf, et al.
Publicado: (2012)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Screening for sequence-specific RNA-BPs by comprehensive UV crosslinking
por: Hartley, Rebecca, et al.
Publicado: (2002)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017)

Magnesium Attenuates Phosphate-Induced Deregulation of a MicroRNA Signature and Prevents Modulation of Smad1 and Osterix during the Course of Vascular Calcification
por: Louvet, Loïc, et al.
Publicado: (2016)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

Non-Coding RNAs in Kidney Diseases: The Long and Short of Them
por: Moreno, Juan Antonio, et al.
Publicado: (2021)

Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate
por: Adoberg, Annika, et al.
Publicado: (2022)

Why are dreams interesting for philosophers? The example of minimal phenomenal selfhood, plus an agenda for future research
por: Metzinger, Thomas
Publicado: (2013)

The myth of cognitive agency: subpersonal thinking as a cyclically recurring loss of mental autonomy
por: Metzinger, Thomas
Publicado: (2013)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

Gut microbiota dynamics and uraemic toxins: one size does not fit all
por: Joossens, Marie, et al.
Publicado: (2019)

Why Is Virtual Reality Interesting for Philosophers?
por: Metzinger, Thomas K.
Publicado: (2018)

Multiple Extrauterine Adenomyomas Presenting in Upper Abdomen and Pelvis: A Case Report and Brief Review of the Literature
por: Moghadamfalahi, Mana, et al.
Publicado: (2012)

The Minimal Phenomenal Experience questionnaire (MPE-92M): Towards a phenomenological profile of “pure awareness” experiences in meditators
por: Gamma, Alex, et al.
Publicado: (2021)

FRI473 Central Hypothyroidism Following Neonatal Graves Presentation
por: Metzinger, Emily, et al.
Publicado: (2023)

Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialyis fluid
por: Glorieux, Griet, et al.
Publicado: (2014)

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA
por: Boelaert, Jente, et al.
Publicado: (2016)

Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial
por: Dhondt, Annemieke, et al.
Publicado: (2015)

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149
por: Boelaert, Jente, et al.
Publicado: (2016)

Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies
por: Vanholder, Raymond, et al.
Publicado: (2008)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cge4fnhrcpjis5kgliegr4dk3r